Farms.com Home   News

PA Farmers Actively Participate In On-Farm Soybean Research

As soybean producers are planting their 2017 crop, a group of Pennsylvania growers are also participating in research projects through the On-Farm Network.
 
The On-Farm Network research is conducted in real-world conditions on test plots planted by Pennsylvania farmers on their own farms with their own equipment to see which management practices have an appreciable impact on production. Research is being conducted at 30 different farm locations in 15 counties throughout Pennsylvania.
 
This year, research will focus on the following:
 
1. Double crop soybean response to lower seeding rate
A second double crop soybean research project will determine if the total number of pods per acre can be increased with lower plant populations.
 
2. Soybean response to reduced seeding rates
Some growers have suggested that lower plant stands near 75,000 may actually promote more pod development, reduce the potential for white mold and reduce seed costs, especially with full season soybeans and full season maturity soybeans. This study is designed to validate the population response at the lower end of traditional soybean seeding rates.
 
3.Soybean yield response to seed treatment fungicides in full season, early planted environment
Seed-applied fungicides can improve yield and plant stands under some situations. This study is designed to provide additional data on the frequency and magnitude of these responses under Pennsylvania conditions.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.